You are here

Article info

Article menu
Immune cell therapies and immune cell engineering
Original research
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling

Authors

  • Kenichi Makino Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USADepartment of Obstetrics and Gynecology, Akita University Graduate School of Medicine School of Medicine, Akita, Japan PubMed articlesGoogle scholar articles
  • Mark D Long Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Ryutaro Kajihara Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Satoko Matsueda Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Takaaki Oba Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USADepartment of Surgery, Shinshu University Graduate School of Medicine School of Medicine, Matsumoto, Nagano, Japan PubMed articlesGoogle scholar articles
  • Kazunori Kanehira Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Song Liu Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA PubMed articlesGoogle scholar articles
  • Fumito Ito Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USADepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USADepartment of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USADepartment of Surgery, University of Southern California, Los Angeles, CA, USA PubMed articlesGoogle scholar articles

Citation

Makino K, Long MD, Kajihara R, et al
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling
Journal for ImmunoTherapy of Cancer 2022;10:e003827. doi: 10.1136/jitc-2021-003827
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.